Workflow
Eterna Therapeutics (ERNA)
icon
Search documents
Eterna Therapeutics (ERNA) - 2019 Q2 - Quarterly Report
2019-08-12 20:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) DELAWARE 31-1103425 (State of incorporation) (I.R.S. Employer Identification No ...
Eterna Therapeutics (ERNA) - 2019 Q2 - Earnings Call Transcript
2019-08-12 14:14
NTN Buzztime, Inc. (NTN) Q2 2019 Earnings Conference Call August 8, 2019 4:30 PM ET Company Participants Kirsten Chapman - LHA, Investor Relations Ram Krishnan - Chief Executive Officer Allen Wolff - Chief Financial Officer Operator Good day, ladies and gentlemen, and welcome to the Q2 2019 NTN Buzztime Inc. Earnings Conference Call. At this time, all participants are in a listen only mode. Later, we will conduct a question-and-answer session and instructions will be given at that time. [Operator Instructio ...
Eterna Therapeutics (ERNA) - 2019 Q1 - Quarterly Report
2019-05-14 20:40
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock NTN NYSE American FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 Commission file number 001-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) DELAWARE 31-1103425 (State of incorporation) (I.R.S. Employer Identification N ...
Eterna Therapeutics (ERNA) - 2019 Q1 - Earnings Call Transcript
2019-05-14 01:19
NTN Buzztime, Inc. (NTN) Q1 2019 Results Earnings Conference Call May 13, 2019 4:30 PM ET Company Participants Kirsten Chapman - LHA, IR Ram Krishnan - CEO Allen Wolff - CFO Conference Call Participants Operator Good day, ladies and gentlemen, and welcome to the First Quarter 2019 NTN Buzztime Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Kirsten Chapman from LHA, Investor Relations. Please g ...
Eterna Therapeutics (ERNA) - 2018 Q4 - Annual Report
2019-03-22 20:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of Each Class Name of Each Exchange on Which Registered Common Stock, $.005 par value NYSE American Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2018 Commission File Number 1-11460 NTN Buzztime, Inc. (Exact name of registrant as specified in its charter) Delaware 31-1103425 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S. ...
Eterna Therapeutics (ERNA) - 2018 Q4 - Earnings Call Transcript
2019-03-21 01:54
NTN Buzztime, Inc. (NTN) Q4 2018 Earnings Conference Call March 20, 2019 4:30 PM ET Company Participants Kirsten Chapman - LHA, IR Ram Krishnan - Director & CEO Allen Wolff - EVP & CFO Conference Call Participants William Gibson - Roth Capital Partners Operator Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2018 NTN Buzztime Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conferenc ...